Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States

scientific article

Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID5402690
P698PubMed publication ID28450816

P2093author name stringLisa D Pedicone
Glen Pietrandoni
Marcelo Kugelmas
Idania Lio
Susan Simon
P2860cites workEradication of Hepatitis C Virus Infection and the Development of Hepatocellular CarcinomaQ22305316
Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United StatesQ26749246
Global epidemiology and genotype distribution of the hepatitis C virus infectionQ27001240
Barriers to hepatitis C treatmentQ27012664
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and PreventionQ28286743
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.Q34101701
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.Q34294185
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.Q35131882
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008Q36100389
Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014Q36858828
Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.Q36858838
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infectionQ42989510
Testing for HCV infection: an update of guidance for clinicians and laboratoriansQ42991914
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisQ42995849
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.Q53118691
P433issue2
P304page(s)98-104
P577publication date2017-02-01
P1433published inGastroenterology & hepatologyQ26842161
P1476titleHepatitis C Point-of-Care Screening in Retail Pharmacies in the United States
P478volume13

Reverse relations

cites work (P2860)
Q61448697Hepatitis C elimination: challenges with under-diagnosis and under-treatment
Q92559755High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing
Q89789952Pharmacy-Based Infectious Diseases Management Programs Incorporating CLIA-Waived Point-of-Care Tests

Search more.